Search for: "Novo Nordisk, Inc."
Results 81 - 100
of 135
Sort by Relevance
|
Sort by Date
24 Jun 2011, 3:25 pm
Novo Nordisk A/SDocket: 10-844Issue(s): Whether the counterclaim provision of the Hatch-Waxman Act applies when (1) there is “an approved method of using the drug” that “the patent does not claim,” and (2) the brand submits “patent information” to the FDA that misstates the patent's scope, requiring “correct[ion]. [read post]
23 Jun 2011, 4:24 am
Seems as though Novo Nordisk has a lot going on. [read post]
10 Jun 2011, 7:11 am
According to DOJ’s press release: Novo Nordisk Inc., a Danish pharmaceutical manufacturer, has agreed to pay $25 million to resolve its civil liability arising from the illegal promotion of its hemostasis management drug, NovoSeven, the Justice Department announced today. [read post]
27 May 2011, 8:56 am
Novo Nordisk A/S . [read post]
24 Mar 2011, 12:53 pm
Novo Nordisk A/SDocket: 10-844Issue(s): Whether the counterclaim provision of the Hatch-Waxman Act applies when (1) there is “an approved method of using the drug” that “the patent does not claim,” and (2) the brand submits “patent information” to the FDA that misstates the patent's scope, requiring “correct[ion]. [read post]
23 Mar 2011, 9:55 am
Novo Nordisk, A/S, 108 F.3d 1361, 1364 (Fed. [read post]
17 Mar 2011, 11:28 am
Food and Drug Administration on the company’s V-Go Disposable Insulin Delivery Device for use with Novo Nordisk’s NovoLog® for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing [...] [read post]
3 Mar 2011, 5:52 pm
Novo Nordisk A/S, 108 F.3d 1361, 1368 (Fed. [read post]
29 Dec 2010, 2:57 am
Sandoz, Inc (IPBiz) (Patent Docs) Plavix (Clopidogrel) – Brazil: Superior Court of Justice denies Plavix patent extension (IP tango) Prandin (Repaglinide) – US: Novo Nordisk and Sandoz settle infringement claims in Prandin dispute (Patent Docs) Prandin (Repaglinide) – US: Supreme Court petitioned to review Federal Circuit patent use code decision: Caraco v Novo Nordisk (FDA Law Blog) [read post]
28 Dec 2010, 10:58 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
8 Dec 2010, 2:20 am
– Nova Biomedical fight for survival following patent threats from Abbott, Roche, Medtronic (IP Directions) Pathogens and the Nagoya Protocol of the Convention on Biological Diversity (PatentlyBIOtech) Australia: Federal Court punishes CSL for amendment delay: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (Patentology) Australia: AusBiotech, legal academics and ARDR weigh in on gene patent debate (Patentology) Australia: Gene patent amendment bill introduced (IP… [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
4 Nov 2010, 10:59 am
Novo Nordisk A/S, 108 F.3d 1361, 1364 (Fed. [read post]
2 Nov 2010, 1:40 am
§ 314.92(a)(1); Novo Nordisk A/S v. [read post]
18 Aug 2010, 12:19 am
Novo Nordisk Pharmaceuticals Pty Ltd; Zetco Pty Ltd v. [read post]
29 Jul 2010, 10:24 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
21 Jul 2010, 1:05 am
Lupin Pharmaceuticals, Inc (FDA Law Blog) Olux (Clobetasol) – Perrigo confirms patent challenge for Colobetasol propionate emulsion foam (GenericsWeb) Prandin (Repaglinide) – US: Actavis, Sandoz bring inequitable conduct counterclaims against Novo Nordisk in Prandin suit (Patent Docs) Protonix (Pantoprazole) – US: District Court New Jersey denies Teva’s motion to overturn jury verdict finding the patent in suit not invalid in Protonix litigation… [read post]
10 Jun 2010, 3:58 am
(FDA Law Blog) Opana (Oxymorphone) - US: Impax Laboratories and Endo Pharmaceuticals settle pending litigation for Opana ER and announce development and co-promotion agreement (SmartBrief) (SmartBrief) (SmartBrief) Prandin (Repaglinide) – US: Patent infringement complaint following a Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
27 May 2010, 3:20 am
(Patent Docs) PrandiMet (Repaglinide and Metformin) – US: Infringement of patent following Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
27 Apr 2010, 2:01 pm
Novo Nordisk A/S, 108 F.3d 1361, 1365 (Fed. [read post]
